Escalon Medical Corp. (ESMC)
OTCMKTS · Delayed Price · Currency is USD
0.177074
+0.000874 (0.50%)
At close: Oct 28, 2026
Escalon Medical Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 1 | 1 | 2 | 1 | 2 | 1 | |
Market Cap Growth | 18.05% | -38.22% | 131.23% | -44.00% | 97.55% | -39.74% |
Enterprise Value | -0 | -0 | 3 | 2 | 3 | 2 |
Last Close Price | 0.18 | 0.20 | 0.32 | 0.14 | 0.25 | 0.13 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 0.65 | 0.74 | 85.45 | - | 8.37 | - |
PS Ratio | 0.10 | 0.12 | 0.20 | 0.09 | 0.15 | 0.09 |
PB Ratio | 0.22 | 0.25 | 1.25 | 0.57 | 0.96 | 0.64 |
P/TBV Ratio | 0.25 | 0.28 | 1.94 | 0.93 | 1.52 | 1.25 |
P/FCF Ratio | - | - | 6.37 | - | 5.82 | - |
P/OCF Ratio | - | - | 6.31 | - | 5.70 | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | - | - | 0.25 | 0.14 | 0.24 | 0.15 |
EV/EBITDA Ratio | - | - | 17.66 | - | 5.59 | - |
EV/EBIT Ratio | - | - | 22.68 | - | 6.12 | - |
EV/FCF Ratio | - | - | 8.02 | - | 9.19 | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 0.16 | 0.16 | 0.27 | 0.29 | 0.46 | 0.82 |
Debt / EBITDA Ratio | 4.13 | 4.13 | 1.01 | 1.86 | 1.03 | - |
Debt / FCF Ratio | - | - | 1.39 | - | 2.79 | - |
Net Debt / Equity Ratio | -0.35 | -0.35 | -0.01 | 0.17 | 0 | 0.41 |
Net Debt / EBITDA Ratio | -30.83 | -30.83 | -0.13 | -5.40 | 0 | -1.45 |
Net Debt / FCF Ratio | 5.14 | 5.14 | -0.06 | -0.49 | 0.00 | -0.58 |
Asset Turnover | 1.80 | 1.80 | 2.47 | 2.38 | 2.32 | 1.97 |
Inventory Turnover | 3.70 | 3.70 | 3.48 | 4.27 | 4.20 | 4.04 |
Quick Ratio | 2.08 | 2.08 | 0.76 | 0.87 | 0.89 | 0.71 |
Current Ratio | 2.94 | 2.94 | 1.72 | 1.65 | 1.63 | 1.39 |
Return on Equity (ROE) | 102.33% | 102.33% | 5.67% | -6.69% | 26.77% | 1.23% |
Return on Assets (ROA) | 0.40% | 0.40% | 1.71% | -1.30% | 5.71% | -5.41% |
Return on Capital Employed (ROCE) | 0.70% | 0.70% | 5.80% | -5.00% | 19.50% | -21.70% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 153.25% | 270.56% | 4.40% | -12.07% | 24.64% | 1.93% |
FCF Yield | -31.00% | -27.45% | 15.70% | -61.94% | 17.18% | -111.88% |
Buyback Yield / Dilution | -2.41% | -2.41% | -92.20% | 45.33% | -82.92% | - |